1690-P: Clinical Outcomes among Nondiabetic Obese Population with Concomitant Metabolic Dysfunction–Associated Steatotic Liver Disease—A Nationwide Study
Obesity, a disease increasing cardiometabolic risks and mortality, often accompanies metabolic dysfunction-associated steatotic liver disease (MASLD). MASLD is characterized by fat accumulation in the liver without other secondary causes. This study explores clinical outcomes in obese patients witho...
Gespeichert in:
Veröffentlicht in: | Diabetes (New York, N.Y.) N.Y.), 2024-06, Vol.73 (Supplement_1), p.1 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!